CVS Health Co. (NYSE:CVS) Stock Position Decreased by Hexagon Capital Partners LLC

Hexagon Capital Partners LLC trimmed its stake in shares of CVS Health Co. (NYSE:CVS) by 3.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 4,933 shares of the pharmacy operator’s stock after selling 179 shares during the period. Hexagon Capital Partners LLC’s holdings in CVS Health were worth $393,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of CVS. Atticus Wealth Management LLC raised its holdings in shares of CVS Health by 149.0% during the fourth quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock valued at $29,000 after acquiring an additional 219 shares during the period. USA Financial Formulas raised its stake in CVS Health by 573.2% during the 4th quarter. USA Financial Formulas now owns 377 shares of the pharmacy operator’s stock valued at $30,000 after purchasing an additional 321 shares during the period. Ables Iannone Moore & Associates Inc. purchased a new stake in shares of CVS Health in the fourth quarter valued at $32,000. Creekmur Asset Management LLC purchased a new position in shares of CVS Health during the fourth quarter valued at $34,000. Finally, Steph & Co. raised its position in CVS Health by 192.0% during the first quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock valued at $35,000 after buying an additional 288 shares during the period. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

Shares of NYSE:CVS opened at $58.14 on Tuesday. The company has a market cap of $72.99 billion, a price-to-earnings ratio of 10.22, a PEG ratio of 0.56 and a beta of 0.52. The business has a 50 day moving average price of $59.56 and a 200 day moving average price of $70.13. The company has a quick ratio of 0.61, a current ratio of 0.81 and a debt-to-equity ratio of 0.78. CVS Health Co. has a twelve month low of $52.77 and a twelve month high of $83.25.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, May 1st. The pharmacy operator reported $1.31 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.38). CVS Health had a net margin of 2.03% and a return on equity of 13.53%. The business had revenue of $88.44 billion during the quarter, compared to the consensus estimate of $89.33 billion. During the same period in the prior year, the company posted $2.20 earnings per share. The firm’s revenue was up 3.7% compared to the same quarter last year. Research analysts predict that CVS Health Co. will post 7.02 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Leerink Partnrs cut CVS Health from an “outperform” rating to a “market perform” rating in a research note on Wednesday, May 1st. Piper Sandler lifted their target price on shares of CVS Health from $93.00 to $94.00 and gave the company an “overweight” rating in a research note on Friday, March 15th. Truist Financial reiterated a “buy” rating and set a $66.00 price objective (down from $90.00) on shares of CVS Health in a report on Thursday, May 2nd. Argus lowered their target price on CVS Health from $100.00 to $80.00 and set a “buy” rating on the stock in a research note on Wednesday, May 8th. Finally, Baird R W raised CVS Health to a “hold” rating in a research note on Thursday, May 30th. Eleven analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $75.05.

Insider Transactions at CVS Health

In related news, Director Edward J. Ludwig bought 1,000 shares of CVS Health stock in a transaction that occurred on Thursday, May 2nd. The stock was acquired at an average price of $53.88 per share, for a total transaction of $53,880.00. Following the completion of the purchase, the director now owns 21,630 shares in the company, valued at $1,165,424.40. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.24% of the company’s stock.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.